EcoDrugPlus

Yes Proto-Oncogene 1, Src Family Tyrosine Kinase

Ensembl ID : ENSECRG00000007054
Gene Symbol: YES1
3 Cross references
265 Possible Orthologues:

Acetylcholinesterase (Cartwright Blood Group)

Ensembl ID : ENSECRG00000009134
Gene Symbol: ACHE
3 Cross references
234 Possible Orthologues:

Activin A Receptor Type 2b

Ensembl ID : ENSECRG00000008957
Gene Symbol: ACVR2B
3 Cross references
259 Possible Orthologues:

Adenosine A1 Receptor B

Ensembl ID : ENSECRG00000006605
Gene Symbol: ADORA1B
1 Cross references
279 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSECRG00000017877
Gene Symbol: ADORA2A
3 Cross references
264 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSECRG00000009144
Gene Symbol: ADORA2B
3 Cross references
199 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSECRG00000011354
Gene Symbol: ADA
3 Cross references
219 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSECRG00000005127
Gene Symbol: LOC114647978
2 Cross references
91 Possible Orthologues:

Adhesion Regulating Molecule 1

Ensembl ID : ENSECRG00000009663
Gene Symbol: ADRM1
3 Cross references
260 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSECRG00000015006
Gene Symbol: ADRA1B
3 Cross references
265 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSECRG00000017317
Gene Symbol: ADRA1D
1 Cross references
196 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSECRG00000006180
Gene Symbol: ADRA2A
3 Cross references
227 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).